Who we are

Innovative Biopharmaceutical Association (IBA) - USA is a nonprofit organization home-based in Greater Philadelphia and dedicated to advancing the communication, translation, and commercialization of cutting-edge scientific discoveries and pharmaceutical R&D innovations. IBA primarily serves U.S.-based academic investigators and biopharmaceutical companies, with a mission to build a high-level national platform that fosters drug development through active engagement of scientists, clinical experts, entrepreneurs, and venture capital partners across the United States.

Leadership Team

IBA Founding Executive Committee

Dr. Ling Yang

Associate Professor

Temple University

Dr. Qing Liang

Founder, Neulink Pharmaceuticals

CEO, NexStage Bio

Dr. Yue Zhu

Senior Director, Global Clinical Development

BioNTech

Dr. Mei Wang

EVP, Global Sales & Marketing & Project Management

Frontage Laboratories